Skip to main content
. 2017 May 17;4:71–79. doi: 10.2147/JHC.S105777

Table 3.

Summary of guideline recommendations on surveillance of non-cirrhotic patients

Recommendations for surveillance of non-cirrhotic livers
European Association for study of the liver (EASL)
 Hepatitis B virus carriers (HBV)
  Adults with family history of HCC (Asian or African)
  Adults with active viral replication (Asian or African)
 Hepatitis C virus (HCV)
  Bridging fibrosis (Metavir F3) and above
American Association for Study of the Liver (AASLD)
 HBV carriers
  Family history of HCC
  African/North American black
Female Asian aged >50 years and male Asian aged >40 years
 Uncertain benefit
  Asian HBV <40-year-old male or 50-year-old female
  HCV with bridging fibrosis (Metavir F3) and above
  Noncirrhotic, nonalcoholic fatty liver disease (NAFLD)
Asian Pacific Association for Study of the Liver (APASL)
 No recommendations for surveillance of non-cirrhotic population

Abbreviation: HCC, hepatocellular carcinoma.